Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Trading Arrangement: Trading Arrangement [Axis] Maximum Maximum [Member] Statistical Measurement [Domain] Statistical Measurement [Domain] Title of 12(b) Security Title of 12(b) Security Subsequent Event Subsequent Event [Member] Net loss attributed to common stockholders Net Income (Loss) Available to Common Stockholders, Diluted Document Fiscal Year Focus Document Fiscal Year Focus Incremental borrowing rate (as a percent) Lessee, Operating Lease, Discount Rate Adjustment to Compensation, Amount Adjustment to Compensation Amount Number of Shares Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Segment Reporting [Abstract] Schedule of Assets Measured at Fair Value on Recurring Basis Fair Value, Assets Measured on Recurring Basis [Table Text Block] Common stock, $0.0001 par value; 335,500,000 shares authorized at June 30, 2026 and December 31, 2025 (303,000,000 voting and 32,500,000 nonvoting); 15,943,937 shares issued at June 30, 2026 and December 31, 2025; and 7,535,986 and 6,685,088 shares outstanding at June 30, 2026 and December 31, 2025, respectively Common Stock, Value, Issued 2027 Lessee, Operating Lease, Liability, to be Paid, Year One Accrued compensation related Employee-related Liabilities, Current Entity Ex Transition Period Entity Ex Transition Period Restatement Determination Date Restatement Determination Date Vesting of restricted common stock (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Amendment Flag Amendment Flag Current liabilities Liabilities, Current [Abstract] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Loss Contingencies [Table] Loss Contingencies [Table] Related Party Transactions Related Party Transactions Disclosure [Text Block] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Entity Address, State or Province Entity Address, State or Province Stock options granted (in shares) Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross PEO Total Compensation Amount PEO Total Compensation Amount Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Assets Assets, Fair Value Disclosure [Abstract] Balance at beginning of period (in shares) Balance at end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Accrued expenses and other current liabilities (includes related party amounts of $389 and $0, respectively) Accrued expenses and other current liabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Weighted-average shares of common stock outstanding, basic (in shares) Weighted-average shares used to compute net loss per share, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Share-Based Payment Arrangement, Tranche One Share-Based Payment Arrangement, Tranche One [Member] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Loss Contingencies [Line Items] Loss Contingencies [Line Items] Number of reportable segments Number of Reportable Segments Voting Common Stock Voting Common Stock [Member] Voting Common Stock Total current liabilities Liabilities, Current Ms. Anderson Chief Development Officer [Member] Chief Development Officer Entity Address, City or Town Entity Address, City or Town Issuance of unvested restricted stock awards (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Statement of Financial Position [Abstract] Title and Position [Domain] Title and Position [Domain] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Share Vesting (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Class of Stock [Axis] Class of Stock [Axis] Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net loss attributed to common stockholders Net Income (Loss) Available to Common Stockholders, Basic (Level 2) Fair Value, Inputs, Level 2 [Member] Other income Nonoperating Income (Expense) [Abstract] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Accrued clinical Accrued Clinical, Current Accrued Clinical, Current Nonvoting Common Stock Nonvoting Common Stock [Member] Recently Issued Accounting Standards Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Grantee Status [Axis] Grantee Status [Axis] Information on Segment Profit or Loss Including Segment Expenses Segment Reporting [Table Text Block] Weighted-average common shares issued Weighted Average Number of Shares Issued, Basic Use of Estimates Use of Estimates, Policy [Policy Text Block] 2026 ESPP 2026 Employee Stock Purchase Plan [Member] 2026 Employee Stock Purchase Plan Related and Nonrelated Parties [Axis] Related and Nonrelated Parties [Axis] Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Less: Segment Reporting, Reconciliation [Abstract] Schedule of Future Minimum Annual Obligation on Sublease Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Purchase price (in dollars per share) Temporary Equity, Redemption Price Per Share Document Period End Date Document Period End Date Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Net cash used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Convertible Preferred Stock and Stockholders’ Deficit Equity [Text Block] Redeemable convertible preferred stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Shares Outstanding (in shares) Temporary Equity, Shares Outstanding Security Exchange Name Security Exchange Name Granted (in dollars per share) Stock options granted, price per share (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Subsidiary or Equity Method Investee [Line Items] Subsidiary or Equity Method Investee [Line Items] 2026 Plan 2026 Stock Option and Incentive Plan [Member] 2026 Stock Option and Incentive Plan Fair value of awards vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Entity Shell Company Entity Shell Company Current portion of lease liabilities Less: current portion of lease liabilities Operating Lease, Liability, Current Net loss per share Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Earnings Per Share [Abstract] Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus 2025 Plan 2025 Stock Option And Grant Plan [Member] 2025 Stock Option And Grant Plan Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Total liabilities Liabilities Trading Symbol Trading Symbol Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Unrecognized compensation cost related to outstanding stock options Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Company Selected Measure Name Company Selected Measure Name Sale of Stock [Domain] Sale of Stock [Domain] Income Tax Disclosure [Abstract] Issuance of Series A redeemable convertible preferred stock, net of nominal issuance costs (in shares) Series A redeemable convertible preferred stock issued (in shares) Temporary Equity, Stock Issued During Period, Shares, New Issues Temporary Equity, Stock Issued During Period, Shares, New Issues Non-cash investing and financing activities: Noncash Investing and Financing Items [Abstract] Redeemable convertible preferred stock, liquidation preference Aggregate Liquidation Preference Temporary Equity, Liquidation Preference Related Party Transactions [Abstract] Cash flows from operating activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Compensation Amount Outstanding Recovery Compensation Amount Individual: Individual [Axis] Weighted-average shares of common stock outstanding, diluted (in shares) Weighted-average shares used to compute net loss per share, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Entity Emerging Growth Company Entity Emerging Growth Company Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Estimated useful lives of property and equipment Property, Plant, and Equipment, Useful Life Underlying Security Market Price Change Underlying Security Market Price Change, Percent Award vesting percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Less: amount representing interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Stock repurchase liability, noncurrent Deferred Compensation Share-Based Arrangements, Liability, Classified, Noncurrent Deferred Offering Costs Deferred Charges, Policy [Policy Text Block] Annual lease payment Operating Lease, Payments Award Timing Predetermined Award Timing Predetermined [Flag] Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition (Level 1) Fair Value, Inputs, Level 1 [Member] Organization, Consolidation and Presentation of Financial Statements [Abstract] Grantee Status [Domain] Grantee Status [Domain] Total minimum lease payments Lessee, Operating Lease, Liability, to be Paid Balance at beginning of period (in dollars per share) Balance at end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value All Executive Categories All Executive Categories [Member] Dr. Murdoch Chief Executive Officer [Member] Forbion Forbion Growth Opportunities Fund III Coöperatief U.A. And Forbion Ventures Fund VII Coöperatief U.A. [Member] Forbion Growth Opportunities Fund III Coöperatief U.A. And Forbion Ventures Fund VII Coöperatief U.A. Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Vesting [Domain] Vesting [Domain] Plan Name [Domain] Plan Name [Domain] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Balance at beginning of period (in dollars per share) Balance at end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Drug Supply Purchases Drug Supply Purchases [Member] Drug Supply Purchases Schedule of Series A Redeemable Convertible Preferred Stock Temporary Equity [Table Text Block] Computation of Basic and Diluted Net Loss Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Fair Value Disclosures [Abstract] Risk-free rate of interest, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Accrued research and development Accrued Research And Development, Current Accrued Research And Development, Current Segment Reporting Segment Reporting [Text Block] Minimum Minimum [Member] Expiration Date Trading Arrangement Expiration Date Denominator: Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Location, Statement of Income, Balance [Axis] Location, Statement of Income, Balance [Axis] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Weighted Average Remaining Contractual Term, Balance at end of period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted-Average Remaining Contractual Term Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Affiliated Entity Affiliated Entity [Member] Options Outstanding, Vested and exercisable at end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Proceeds from issuance of common stock Proceeds from Issuance of Common Stock Common stock, shares authorized (in shares) Common Stock, Shares Authorized Numerator: Earnings Per Share Reconciliation [Abstract] Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Security, Excluded EPS Calculation [Table] Number of shares sold (in shares) Sale of Stock, Number of Shares Issued in Transaction Non-Voting Series A redeemable convertible preferred stock Nonvoting Series A Redeemable Convertible Preferred Stock [Member] Nonvoting Series A Redeemable Convertible Preferred Stock Exercise Price Award Exercise Price Cash flows from investing activities: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Vesting of restricted common stock Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Weighted-average remaining lease term Lessee, Operating Lease, Remaining Lease Term Related Party Transaction [Axis] Related Party Transaction [Axis] Segment Reporting [Line Items] Segment Reporting [Line Items] Document Quarterly Report Document Quarterly Report Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Segments [Domain] Segments [Domain] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Property and Equipment Property, Plant, and Equipment [Policy Text Block] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Equity Component [Domain] Equity Component [Domain] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Aggregate gross proceeds Sale of Stock, Consideration Received on Transaction Adoption Date Trading Arrangement Adoption Date Counterparty Name [Domain] Counterparty Name [Domain] Total stockholders’ deficit Beginning balance Ending balance Equity, Attributable to Parent Total other income Other income Nonoperating Income (Expense) Assets Assets [Abstract] Title Trading Arrangement, Individual Title Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Accounting Policies [Abstract] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Operating lease liability Present value of lease liabilities Operating Lease, Liability Payments for deferred offering costs Payments of Stock Issuance Costs Insider Trading Policies and Procedures [Line Items] Balance at beginning of period (in shares) Balance at end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Balance Sheet Details Supplemental Balance Sheet Disclosures [Text Block] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Number of operating segments Number of Operating Segments Total Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Central Index Key Entity Central Index Key All Adjustments to Compensation All Adjustments to Compensation [Member] Equity [Abstract] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Net cash used in operating activities Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Income Statement [Abstract] Stockholders’ deficit Equity, Attributable to Parent [Abstract] Document Transition Report Document Transition Report Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Operating expenses Operating Expenses [Abstract] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Schedule of Assumptions in Fair Value of Options Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Options Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] City Area Code City Area Code Outside of the 2025 Plan Other Than The 2025 Plan [Member] Other Than The 2025 Plan Unvested restricted common stock RSA Restricted Stock [Member] All Individuals All Individuals [Member] Subsequent Events Subsequent Events [Text Block] Name Forgone Recovery, Individual Name Unrecognized compensation cost, recognition period Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Weighted-Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Statement [Line Items] Statement [Line Items] Total assets Assets Total common stock reserved for issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance IPO anniversary period Share-Based Payment Arrangement, Plan Modification, IPO Anniversary Period Share-Based Payment Arrangement, Plan Modification, IPO Anniversary Period Weighted-average grant date fair value of options granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Schedule of Stock-Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Number of shares with modification Share-Based Payment Arrangement, Plan Modification, Number Of Shares Share-Based Payment Arrangement, Plan Modification, Number Of Shares Equity Incentive Plan and Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Facilities Occupancy, Net Description of Business Nature of Operations [Text Block] Issuance of founders shares (in shares) Stock Issued During Period, Shares, New Issues PEO PEO [Member] Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Stock-based compensation expense Share-Based Payment Arrangement, Expense Other long-term liabilities Other Liabilities, Noncurrent Increase in authorized shares (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Issuance of unvested restricted stock awards (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Subsequent Event Type [Domain] Subsequent Event Type [Domain] Accumulated Deficit Retained Earnings [Member] Lease liabilities, net of current portion Operating Lease, Liability, Noncurrent Total operating expenses Operating Expenses Money market funds Money Market Funds [Member] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Issuance of Series A redeemable convertible preferred stock, net of nominal issuance costs Temporary Equity, Stock Issued During Period Including Deemed Dividends, Value, New Issues Temporary Equity, Stock Issued During Period Including Deemed Dividends, Value, New Issues Common stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Award Timing Disclosures [Line Items] Net loss per share, diluted (in dollars per share) Net loss per share attributable to common stockholders, diluted (in dollars per share) Earnings Per Share, Diluted Entity Current Reporting Status Entity Current Reporting Status Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Expected stock price volatility, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Total Shareholder Return Amount Total Shareholder Return Amount Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Operating lease right-of-use asset and lease liabilities Increase (Decrease) In Operating Lease Right-Of-Use Assets And Lease Liabilities, Net Increase (Decrease) In Operating Lease Right-Of-Use Assets And Lease Liabilities, Net Adjustments to reconcile net loss to net cash used in operations: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Redeemable convertible preferred stock, par value (in dollars per share) Temporary Equity, Par or Stated Value Per Share IPO IPO [Member] Share-Based Payment Arrangement [Abstract] Cash flows from financing activities: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Property and equipment, net Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization Flipping Transaction provision, period Related Party Transaction, Flipping Transaction Provision, Period Related Party Transaction, Flipping Transaction Provision, Period Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Underlying Securities Award Underlying Securities Amount Issuance of founders shares Stock Issued During Period, Value, New Issues Underwriter's Option Over-Allotment Option [Member] Forfeited (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Risk-free rate of interest, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Schedule of Restricted Stock Activity Nonvested Restricted Stock Shares Activity [Table Text Block] Segment Reporting [Table] Segment Reporting [Table] Number of shares of common stock available for issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Related Party Transaction [Table] Related Party Transaction [Table] Title and Position [Axis] Title and Position [Axis] Sale of Stock [Axis] Sale of Stock [Axis] Weighted Average Remaining Contractual Term and Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Mr. Rickey Chief Financial Officer [Member] Commitments and Contingencies Disclosure [Abstract] All Trading Arrangements All Trading Arrangements [Member] Other Performance Measure, Amount Other Performance Measure, Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Loss from operations Operating Income (Loss) Current Fiscal Year End Date Current Fiscal Year End Date Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Related Party Transaction [Domain] Related Party Transaction [Domain] Series A redeemable convertible preferred stock issued, value Issuance of Series A redeemable convertible preferred stock, net of nominal issuance costs Temporary Equity, Stock Issued During Period, Value, New Issues Deemed dividends on issuance of Series A redeemable convertible preferred stock Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Entity File Number Entity File Number Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Summary of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Weighted Average Exercise Price Per Share Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Common stock, shares issued (in shares) Common Stock, Shares, Issued Measure: Measure [Axis] Equity Components [Axis] Equity Components [Axis] Deferred offering costs Deferred Costs, Noncurrent Related Party Related Party [Member] Class of Stock [Line Items] Class of Stock [Line Items] Entity Interactive Data Current Entity Interactive Data Current License milestones License Milestone Expense License Milestone Expense Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Entity Small Business Entity Small Business Termination Date Trading Arrangement Termination Date Property, Plant, and Equipment [Line Items] Property, Plant, and Equipment [Line Items] Subsequent Events [Abstract] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Reverse stock split ratio Stockholders' Equity Note, Stock Split, Conversion Ratio MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Other long-term assets Other Assets, Noncurrent Document Type Document Type Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Issuance costs of Series A redeemable convertible preferred stock Temporary Equity, Stock Issuance Costs Temporary Equity, Stock Issuance Costs Accrued expenses and other current liabilities (includes related party amounts of $389 and $3,272, respectively) Accrued expenses and other current liabilities Total accrued expenses and other current liabilities Accrued Liabilities, Current Fair Value as of Grant Date Award Grant Date Fair Value Increase (Decrease) in Temporary Equity [Roll Forward] Increase (Decrease) in Temporary Equity [Roll Forward] In-process research and development Acquired in-process research and development Research and Development Asset Acquired in Transaction Other than Business Combination or Joint Venture Formation, Writeoff Aggregate Intrinsic Value, Vested and exercisable at end of period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Arrangement Duration Trading Arrangement Duration Subsequent Event [Line Items] Subsequent Event [Line Items] Statement of Stockholders' Equity [Abstract] Local Phone Number Local Phone Number Redeemable convertible preferred stock, shares authorized (in shares) Shares Authorized (in shares) Temporary Equity, Shares Authorized Entity Address, Postal Zip Code Entity Address, Postal Zip Code Registrant Name Entity Registrant Name Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Commitments and contingencies (Note 6) Commitments and Contingencies Revenue Revenues Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Executive Category: Executive Category [Axis] Award vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Counterparty Name [Axis] Counterparty Name [Axis] Liabilities, redeemable convertible preferred stock, and stockholders’ deficit Liabilities and Equity [Abstract] Weighted Average Remaining Contractual Term, Vested and exercisable at end of period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted-Average Remaining Contractual Term Cash paid for purchased in-process research and development (includes related party amounts of $3,000 and $0, respectively) Cash paid for purchased in-process research and development Payments to Acquire in Process Research and Development Series A redeemable convertible preferred stock, $0.0001 par value Beginning balance Ending balance Carrying Value Temporary Equity, Carrying Amount, Attributable to Parent OrbiMed OrbiMed Private Investments IX, LP [Member] OrbiMed Private Investments IX, LP Series A redeemable convertible preferred stock Series A Redeemable Convertible Preferred Stock [Member] Series A Redeemable Convertible Preferred Stock All Award Types Award Type [Domain] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount 2026 (remaining) Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Fair Value Measurements Fair Value Disclosures [Text Block] (Level 3) Fair Value, Inputs, Level 3 [Member] Supplemental disclosure of cash flow information: Supplemental Cash Flow Information [Abstract] Expected term (years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Initial lease term Lessee, Operating Lease, Term of Contract PEO Name PEO Name Redeemable convertible preferred stock, shares issued (in shares) Shares Issued (in shares) Temporary Equity, Shares Issued Other Segment Reporting, Other Segment Item, Amount Volume weighted average trading price, threshold trading days Volume Weighted Average Trading Price, Threshold Trading Days Volume Weighted Average Trading Price, Threshold Trading Days Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Entity Tax Identification Number Entity Tax Identification Number Accrued deferred offering and issuance costs Accrued Deferred Offering And Issuance Costs, Current Accrued Deferred Offering And Issuance Costs, Current Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Cash and cash equivalents at beginning of the period Cash and cash equivalents at end of the period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Accrued professional services Accrued Professional Fees, Current Accounts payable Increase (Decrease) in Accounts Payable Other accrued expenses Other Accrued Liabilities, Current Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Non-NEOs Non-NEOs [Member] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Employee Share-Based Payment Arrangement, Employee [Member] Subsequent Event [Table] Subsequent Event [Table] Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Personnel-related Labor and Related Expense Proceeds from issuance of Series A redeemable convertible preferred stock, net of issuance costs Proceeds from Issuance of Redeemable Convertible Preferred Stock Number of common stock issued upon conversion of redeemable convertible preferred stock (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Net loss per share, basic (in dollars per share) Net loss per share attributable to common stockholders, basic (in dollars per share) Earnings Per Share, Basic Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Insider Trading Arrangements [Line Items] Less: deemed dividend to preferred stockholders Non-cash deemed dividends on Series A redeemable convertible preferred stock Deemed dividends upon issuance of redeemable convertible preferred stock Redeemable Preferred Stock Dividends Award Type Award Type [Axis] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Options vested, weighted average exercise price (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Vested In Period, Weighted Average Exercise Price Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Vested In Period, Weighted Average Exercise Price Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Reportable Segment Reportable Segment [Member] Reportable Segment Less: Weighted-average common shares subject to repurchase and vesting conditions Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Common Stock Common Stock [Member] Volume weighted average trading price exceeds the original issuance price of redeemable convertible preferred stock, period Volume Weighted Average Trading Price Greater Than The Original Issuance Price Of Redeemable Convertible Preferred Stock, Period Volume Weighted Average Trading Price Greater Than The Original Issuance Price Of Redeemable Convertible Preferred Stock, Period Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Cover [Abstract] Volume weighted average trading price, original issuance price of redeemable convertible preferred stock, multiplier Volume Weighted Average Trading Price, Original Issuance Price Of Redeemable Convertible Preferred Stock, Multiplier Volume Weighted Average Trading Price, Original Issuance Price Of Redeemable Convertible Preferred Stock, Multiplier Dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate External research and development External Research And Development Expense External Research And Development Expense Equity Awards Adjustments Equity Awards Adjustments [Member] Total liabilities, redeemable convertible preferred stock, and stockholders’ deficit Liabilities and Equity Common stock options granted and outstanding Stock options Common stock options outstanding Share-Based Payment Arrangement, Option [Member] Shares of Common Stock issuable upon conversion (in shares) Preferred Stock, Convertible, Shares Issuable License Agreement for Completed Manufacturing Technology Transfer Milestone License Agreement For Completed Manufacturing Technology Transfer Milestone [Member] License Agreement For Completed Manufacturing Technology Transfer Milestone Segments [Axis] Segments [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Plan Name [Axis] Plan Name [Axis] Related and Nonrelated Parties [Domain] Related and Nonrelated Parties [Domain] AH Bio AH Bio Fund IV, L.P. [Member] AH Bio Fund IV, L.P. Tabular List, Table Tabular List [Table Text Block] Vesting [Axis] Vesting [Axis] Additional paid-in capital Additional Paid in Capital Name Awards Close in Time to MNPI Disclosures, Individual Name Number of options vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Aggregate Intrinsic Value at end of period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value General and administrative (includes nominal related party amounts for the three and six months ended June 30, 2026, respectively) General and Administrative Expense Offering price (in dollars per share) Sale of Stock, Price Per Share Undesignated preferred stock (in shares) Preferred Stock, Shares Authorized Property, Plant, and Equipment [Table] Property, Plant, and Equipment [Table] Adjustment to Compensation: Adjustment to Compensation [Axis] Class of Stock [Domain] Class of Stock [Domain] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Statement of Cash Flows [Abstract] Top-line clinical results, period after first public disclosure Share-Based Payment Arrangement, Plan Modification, Topline Clinical Results, Period After First Public Disclosure Share-Based Payment Arrangement, Plan Modification, Topline Clinical Results, Period After First Public Disclosure Schedule of Common Stock Reserved for Future Issuance Schedule of Stock by Class [Table Text Block] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Total fair value of assets Assets, Fair Value Disclosure Name Measure Name Income Taxes Income Tax Disclosure [Text Block] Accounts payable (includes related party amounts of $0 and $73, respectively) Accounts payable Accounts Payable, Current Pay vs Performance Disclosure [Line Items] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Certain Employees and Non-Employee Consultants Certain Employees And Non-Employee Consultants [Member] Certain Employees And Non-Employee Consultants Additional Paid-In Capital Additional Paid-in Capital [Member] Entity Filer Category Entity Filer Category Subsidiary or Equity Method Investee, Sale of Stock [Table] Subsidiary or Equity Method Investee, Sale of Stock [Table] Name Trading Arrangement, Individual Name Unrecognized compensation cost related to outstanding awards other than options Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Cash and cash equivalents Cash and Cash Equivalent IPO Grants 2026 Plan (Collectively the “IPO Grants”) [Member] 2026 Plan (Collectively the “IPO Grants”) Rent expense Operating Lease, Expense Company Selected Measure Amount Company Selected Measure Amount Depreciation and amortization Depreciation, Depletion and Amortization Stock, Class of Stock [Table] Stock, Class of Stock [Table] Current assets Assets, Current [Abstract] Non-PEO NEO Non-PEO NEO [Member] Accrued license milestone Accrued licensing, related party Accrued Licensing, Related Party, Current Accrued Licensing, Related Party, Current Entity Address, Address Line One Entity Address, Address Line One Right-of-use assets obtained in connection with operating lease obligations Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Share Vesting (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Deferred offering costs in accounts payable and accrued liabilities Deferred Offering Costs Incurred But Not Yet Paid Deferred Offering Costs Incurred But Not Yet Paid Other income Other Nonoperating Income Award Timing Method Award Timing Method [Text Block] Net increase in cash and cash equivalents for the period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Research and development (includes related party amounts of $389 and $6,389 for the three and six months ended June 30, 2026, respectively) Research and development Research and Development Expense (Excluding Acquired in Process Cost) Expected stock price volatility, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Net loss Net loss Net Income (Loss) Attributable to Parent Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Statement [Table] Statement [Table] Share-Based Payment Arrangement, Tranche Two Share-Based Payment Arrangement, Tranche Two [Member] Proceeds from IPO Proceeds from Issuance Initial Public Offering Redeemable convertible preferred stock Common stock issuable upon conversion of Series A redeemable convertible preferred stock Redeemable Convertible Preferred Stock [Member] Restatement Determination Date: Restatement Determination Date [Axis] Nonemployee Share-Based Payment Arrangement, Nonemployee [Member] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Interest income Investment Income, Interest Weighted Average Exercise Price Per Share, Vested and exercisable at end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Operating Leases Lessee, Leases [Policy Text Block] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Shares available for issuance under the 2025 equity incentive plan Share-Based Payment Arrangement [Member] Summary of Significant Accounting Policies Basis of Presentation and Significant Accounting Policies [Text Block] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block]